Tumour-associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles.

Kumar, Pankaj; Boyne, Caitlin; Brown, Sydney; Qureshi, Ayesha; Thorpe, Peter; Synowsky, Silvia A; Shirran, Sally; Powis, Simon J

Kumar, Pankaj; Boyne, Caitlin; Brown, Sydney; Qureshi, Ayesha; Thorpe, Peter; Synowsky, Silvia A; Shirran, Sally; Powis, Simon J.

Afiliação

Kumar P; School of Medicine, University of St Andrews, St Andrews, UK.
Boyne C; School of Medicine, University of St Andrews, St Andrews, UK.
Brown S; School of Medicine, University of St Andrews, St Andrews, UK.
Qureshi A; School of Medicine, University of St Andrews, St Andrews, UK.
Thorpe P; School of Medicine, University of St Andrews, St Andrews, UK.
Synowsky SA; School of Biology, University of St Andrews, St Andrews, UK.
Shirran S; Biomedical Sciences Research Complex, University of St Andrews, St Andrews, UK.
Powis SJ; School of Biology, University of St Andrews, St Andrews, UK.

Immunology ; 166(2): 249-264, 2022 06.

Article em En | MEDLINE | ID: mdl-35318648

Assuntos

Carcinoma Hepatocelular; Vesículas Extracelulares; Neoplasias Hepáticas; Antígenos de Neoplasias; Linfócitos T CD8-Positivos; Carcinoma Hepatocelular/metabolismo; Linhagem Celular; Antígenos de Histocompatibilidade Classe I/metabolismo; Humanos; Ligantes; Neoplasias Hepáticas/metabolismo; Peptídeos

Palavras-chave

HLA ligandome; T-cell epitopes; breast cancer; extracellular vesicles; tumour associated antigen (TAA)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Vesículas Extracelulares / Neoplasias Hepáticas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Immunology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google